Dr. Hirsch discusses the promising efficacy and safety of cevertinib for HER2-mutant non-small cell lung cancer, highlighting ...
Jeddah, Saudi Arabia: The Islamic Development Bank (IsDB), together with the Massachusetts Institute of Technology (MIT) ...
Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of MRI concordance in imaging study of patients with brain metastases Interim data ...
Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver high concentrations of IL-15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results